Colin Noble

2.8k total citations
52 papers, 1.2k citations indexed

About

Colin Noble is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Colin Noble has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 19 papers in Immunology and 15 papers in Surgery. Recurrent topics in Colin Noble's work include Inflammatory Bowel Disease (29 papers), Microscopic Colitis (13 papers) and Biosimilars and Bioanalytical Methods (8 papers). Colin Noble is often cited by papers focused on Inflammatory Bowel Disease (29 papers), Microscopic Colitis (13 papers) and Biosimilars and Bioanalytical Methods (8 papers). Colin Noble collaborates with scholars based in United Kingdom, United States and Spain. Colin Noble's co-authors include Jack Satsangi, Charlie W. Lees, Ian Arnott, Gwo‐Tzer Ho, Alan G. Shand, Marian C. Aldhous, Jack Satsangi, Nicholas A. Kennedy, Nikolas Plevris and Ian Penman and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Colin Noble

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Noble United Kingdom 20 648 396 316 286 253 52 1.2k
Nobuyuki Hida Japan 20 691 1.1× 496 1.3× 337 1.1× 422 1.5× 165 0.7× 57 1.2k
Klaudia Farkas Hungary 21 784 1.2× 594 1.5× 382 1.2× 507 1.8× 236 0.9× 155 1.5k
Ray Boyapati Australia 12 410 0.6× 303 0.8× 233 0.7× 286 1.0× 282 1.1× 37 942
Daniel JB Marks United Kingdom 17 627 1.0× 406 1.0× 693 2.2× 263 0.9× 302 1.2× 41 1.5k
D Ludwig Germany 23 496 0.8× 426 1.1× 231 0.7× 447 1.6× 273 1.1× 52 1.4k
Ágota Kovács Hungary 17 631 1.0× 491 1.2× 231 0.7× 260 0.9× 140 0.6× 43 1.0k
J.F. Colombel France 15 800 1.2× 616 1.6× 194 0.6× 354 1.2× 254 1.0× 52 1.2k
Helena Tavares de Sousa Portugal 13 904 1.4× 658 1.7× 232 0.7× 320 1.1× 110 0.4× 39 1.2k
Daniel R. Gaya United Kingdom 21 665 1.0× 563 1.4× 203 0.6× 544 1.9× 202 0.8× 82 1.4k
Alexander Teml Austria 17 822 1.3× 456 1.2× 314 1.0× 307 1.1× 305 1.2× 24 1.7k

Countries citing papers authored by Colin Noble

Since Specialization
Citations

This map shows the geographic impact of Colin Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Noble more than expected).

Fields of papers citing papers by Colin Noble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Noble. The network helps show where Colin Noble may publish in the future.

Co-authorship network of co-authors of Colin Noble

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Noble. A scholar is included among the top collaborators of Colin Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Noble. Colin Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gros, Beatriz, Nikolas Plevris, Mathew Lyons, et al.. (2025). Twenty‐Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland. Alimentary Pharmacology & Therapeutics. 62(7). 699–709.
2.
Gros, Beatriz, Lauranne Derikx, Mathew Lyons, et al.. (2024). Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therapeutic Advances in Gastroenterology. 17. 1118441348–1118441348. 6 indexed citations
3.
Gros, Beatriz, J D Kennedy, Colin Noble, et al.. (2024). Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison. Journal of Crohn s and Colitis. 19(7).
4.
Gros, Beatriz, Nikolas Plevris, Mathew Lyons, et al.. (2023). Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort. United European Gastroenterology Journal. 11(2). 179–188. 12 indexed citations
5.
Miller, J. D., Yasuko Maeda, L. Arlene Porteous, et al.. (2021). Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection. Colorectal Disease. 23(7). 1639–1648. 11 indexed citations
6.
Repici, Alessandro, Emmanuel Coron, Prateek Sharma, et al.. (2019). Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution. Digestive and Liver Disease. 51(12). 1671–1677. 10 indexed citations
7.
Jones, Gareth‐Rhys, Mathew Lyons, Nikolas Plevris, et al.. (2019). IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology. Gut. 68(11). 1953–1960. 137 indexed citations
8.
Tsim, Selina, Catherine Humphreys, Gordon W. Cowell, et al.. (2018). Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy. Lung Cancer. 118. 48–56. 22 indexed citations
9.
Ho, Gwo‐Tzer, Rhona Aird, Ray Boyapati, et al.. (2017). MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunology. 11(1). 120–130. 88 indexed citations
10.
Adams, Alex, Nicholas A. Kennedy, Richard Hansen, et al.. (2014). Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohnʼs Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci. Inflammatory Bowel Diseases. 20(10). 1784–1793. 61 indexed citations
11.
Koulaouzidis, Anastasios, Alexandros Karargyris, Emanuele Rondonotti, et al.. (2013). Three-dimensional representation software as image enhancement tool in small-bowel capsule endoscopy: A feasibility study. Digestive and Liver Disease. 45(11). 909–914. 23 indexed citations
12.
Nimmo, Elaine R., Craig Stevens, Anne Phillips, et al.. (2011). TLE1 Modifies the Effects of NOD2 in the Pathogenesis of Crohn's Disease. Gastroenterology. 141(3). 972–981.e2. 31 indexed citations
13.
Noble, Colin, Alexander R. Abbas, Charlie W. Lees, et al.. (2010). Characterization of intestinal gene expression profiles in Crohnʼs disease by genome-wide microarray analysis. Inflammatory Bowel Diseases. 16(10). 1717–1728. 73 indexed citations
14.
Aldhous, Marian C., Colin Noble, & Jack Satsangi. (2009). Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease. PLoS ONE. 4(7). e6285–e6285. 67 indexed citations
15.
Noble, Colin, John McCullough, Wendy Ho, et al.. (2008). Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 27(7). 588–596. 31 indexed citations
16.
Noble, Colin, Alexander R. Abbas, Jan F. Cornelius, et al.. (2008). Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut. 57(10). 1398–1405. 153 indexed citations
17.
Lees, Charlie W., Gwo‐Tzer Ho, Colin Noble, et al.. (2007). A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics. 26(3). 411–419. 109 indexed citations
18.
Törkvist, Leif, Colin Noble, Mikael Lördal, et al.. (2006). Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden. Scandinavian Journal of Gastroenterology. 41(6). 700–705. 22 indexed citations
19.
Törkvist, Leif, Colin Noble, Mikael Lördal, et al.. (2006). Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scandinavian Journal of Gastroenterology. 42(2). 200–206. 20 indexed citations
20.
Noble, Colin, et al.. (2005). DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut. 54(10). 1416–1420. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuyuki Hida Breakdown of academic impact, for papers by Klaudia Farkas Breakdown of academic impact, for papers by Ray Boyapati Breakdown of academic impact, for papers by Daniel JB Marks Breakdown of academic impact, for papers by D Ludwig Breakdown of academic impact, for papers by Ágota Kovács Breakdown of academic impact, for papers by J.F. Colombel Breakdown of academic impact, for papers by Helena Tavares de Sousa Breakdown of academic impact, for papers by Daniel R. Gaya Breakdown of academic impact, for papers by Alexander Teml
Rankless by CCL
2026